Highlights the rare but severe complication of pulmonary arterial hypertension following pediatric hematopoietic stem cell transplantation, requiring a high index of suspicion.
PH is a rare condition with high mortality rate after pediatric HSCT. As clinical presentation is non-specific and may mimic other conditions, a high degree of suspicion is required for diagnosis. Here, we present a patient with stage-IV neuroblastoma who developed PAH after autologous HSCT. After exclusion of other causes of PH, we regarded that this condition was secondary to HSCT.
No takes yet. Share an insight, caveat, or question.
Özyörük et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: